These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3324957)

  • 1. Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.
    Joly V; Pangon B; Vallois JM; Abel L; Brion N; Bure A; Chau NP; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1632-9. PubMed ID: 3324957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.
    Pangon B; Joly V; Vallois JM; Abel L; Buré A; Brion N; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1987 Apr; 31(4):518-22. PubMed ID: 3300530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the therapeutic effect of cephalosporins in experimental endocarditis by altering their pharmacokinetics with diclofenac.
    Joly V; Pangon B; Brion N; Vallois JM; Carbon C
    J Pharmacol Exp Ther; 1988 Aug; 246(2):695-700. PubMed ID: 3042958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
    Fantin B; Pangon B; Potel G; Caron F; Vallée E; Vallois JM; Mohler J; Buré A; Philippon A; Carbon C
    Antimicrob Agents Chemother; 1990 Apr; 34(4):581-6. PubMed ID: 2188586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.
    Fantin B; Pangon B; Potel G; Vallois JM; Caron F; Bure A; Carbon C
    Antimicrob Agents Chemother; 1989 May; 33(5):767-70. PubMed ID: 2665645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone diffusion into cardiac fibrin vegetation. Qualitative and quantitative evaluation by autoradiography.
    Crémieux AC; Mazière B; Vallois JM; Ottaviani M; Bouvet A; Pocidalo JJ; Carbon C
    Fundam Clin Pharmacol; 1991; 5(1):53-60. PubMed ID: 2066051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding.
    Potel G; Chau NP; Pangon B; Fantin B; Vallois JM; Faurisson F; Carbon C
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2085-90. PubMed ID: 1759831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
    Contrepois A; Daldoss C; Pangon B; Garaud JJ; Kecir M; Sarrazin C; Vallois JM; Carbon C
    J Antimicrob Chemother; 1984 Jul; 14(1):51-7. PubMed ID: 6384175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J; López P; Martín T; Gomis X; Ramírez JL; Azuaje C; Almirante B; Pahissa A
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
    J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.
    Caron F; Gutmann L; Bure A; Pangon B; Vallois JM; Pechinot A; Carbon C
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2070-4. PubMed ID: 2073099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
    Cremieux AC; Saleh-Mghir A; Vallois JM; Maziere B; Muffat-Joly M; Devine C; Bouvet A; Pocidalo JJ; Carbon C
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.
    Blatter M; Fluckiger U; Entenza J; Glauser MP; Francioli P
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1971-6. PubMed ID: 8239615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.
    Chambers HF; Basuino L; Hamilton SM; Choo EJ; Moise P
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3976-9. PubMed ID: 27090173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
    Entenza JM; Blatter M; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2683-8. PubMed ID: 7695248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis
    Kebriaei R; Rice SA; Stamper KC; Seepersaud R; Garcia-de-la-Maria C; Mishra NN; Miro JM; Arias CA; Tran TT; Sullam PM; Bayer AS; Rybak MJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
    del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
    Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography.
    Cremieux AC; Maziere B; Vallois JM; Ottaviani M; Azancot A; Raffoul H; Bouvet A; Pocidalo JJ; Carbon C
    J Infect Dis; 1989 May; 159(5):938-44. PubMed ID: 2523432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of Ceftaroline plus Ampicillin against Enterococcus faecalis in an
    Werth BJ; Shireman LM
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.